SciDoc Publishers | Open Access | Science Journals | Media Partners


International Journal of Dentistry and Oral Science (IJDOS)  /  IJDOS-2377-8075-08-608

Management Of Tooth With Deep Furcal Defect By Endo- Perio Management – An Interdisciplinary Case Report


Swarna S.K1, Nivedhitha2*

1 Department of Conservative Dentistry & Endodontics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India.

2 Professor and Head, Department of Conservative Dentistry and Endodontics, Saveetha Dental college and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University , Chennai, India.


*Corresponding Author

Dr. Nivedhitha. M.S,
Professor and Head, Department of Conservative Dentistry and Endodontics, Saveetha Dental college and Hospital, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India.
E-mail: nivedhitha.sdc@saveetha.com

Received: May 28, 2021; Accepted: June 17, 2021; Published: June 19, 2021

Citation: Swarna S.K, Nivedhitha. Management Of Tooth With Deep Furcal Defect By Endo- Perio Management - An Interdisciplinary Case Report. Int J Dentistry Oral Sci. 2021;8(6):2710-2717.doi: dx.doi.org/10.19070/2377-8075-21000531

Copyright: Nivedhitha©2021. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.



Abstract

Multi disciplinary approach was followed in treatment of endo perio lesion in a mandibular molar with furcal involvement and apical lesion. The patient presented with pain and mobility in the right mandibular first molar. There was grade I mobility and periapical lesion along with furcal involvement in relation to 46. A probing depth of 7mm was elicited in relation to buccal aspect of 46. The endodontic management of 46 was done using sonic activation of irrigant along with calcium hydroxide intracanal medicament. Periodontal flap surgery along with placement of bone graft and Platelet rich fibrin was done to facilitate healing kinetics of periapical healing as well as periodontal regeneration. The patient was recalled after 1,3,6 months and at one year follow up, complete healing of the furcal defect was seen in 46.



1.Keywords
2.Introduction
3.Materials and Methods
4.Statistical Analysis
5.Results and Discussion
6.Conclusion
7.Acknowledgments
8.References


Keywords

Bone Graft; Calcium Hydroxide; Endo-Perio Lesion; Platelet Rich Fibrin (PRF); Sonic Irrigant Activation.


Introduction

The pulp and periodontium are interconnected embryologically, anatomically and functionally. Endo-perio lesion is a clinical manifestation of pathologic/ inflammatory intercommunication between pulpal and periodontal tissues via open structures such as apical foramina, dentinal tubules and lateral accessory canals [1]. The relationship between pulp and periodontium was first discovered by Simring and Goldberg in 1964 [2]. Endodontic- periodontal problems are responsible for more than 50% of tooth mortality and the prognosis depends on identifying and eliminating the etiological factors for the disease process [3, 4]. The pathways of communication responsible for endo perio lesions include lateral and accessory canals, dentinal tubules and apical foramen [5]. Simon et al has classified endo perio lesions based on the primary origin of the disease process and the extent of involvement in the pulpal and periodontal tissues [6].

Accessory canals in the furcal area of molars paves a direct pathway of communication between the pulp and periodontium [7, 8]. The incidence of these canals may vary from 23% to 76% [9-11]. These accessory canals communicate with pulp and periodontium by means of connective tissue and blood vessels. Accessory canals are concentrated at the apical delta region and lateral canals in the furcal region [12]. Seltzer et al, has reported that inflammation of pulp may cause inflammatory reactions in the interradicular periodontal tissues [13, 14]. The treatment of endo perio lesion presents a challenge to the clinician and the prognosis of a tooth with endo perio lesion depends on identifying the cause and establishing the appropriate diagnosis [15].

Disinfection of teeth with pulp necrosis and apical periodontitis is augmented with efficient irrigant activation [16] for dislodgement of biofilms and debris and placement of intracanal medication facilitates increased contact time to eliminate the microbes [17]. Platelet concentrates are rich in growth factors and aid in effectively initiating the bone repair and healing by proliferation, chemotaxis and differentiation of locally derived progenitor cells [18].

Bone replacement grafts serve as a framework for blood clot formation and maturation and support the formation of bone in osseous defects [19, 20].

Previously our team has a rich experience in working on various research projects across multiple disciplines [21-35] Now the growing trend in this area motivated us to pursue this project.


Case Report

A 24 year old male patient reported to our dental outpatient department with the chief complaint of pain and mobility in the right lower back tooth for the past 3 months that pain aggravated while chewing food. Patient revealed a history of restoration in the right lower back tooth region before 5 years.The medical history was non contributory. On clinical examination, there was dislodged restoration in relation to 46(Figure 1A). There was grade I mobility in relation to 46 [36]. The probing depth was 7mm in the furcal region in relation to the buccal aspect of 46. Pulp sensibility tests such as electric pulp test (Gentle Pulse™ Pulp Vitality Tester, Parkell, USA) and cold test (Coltene/Whaledent, Switzerland) showed no response and confirmed that the tooth was non vital. Tenderness on percussion was present in relation to 46. Radiographic examination using Intra Oral Periapical Radiograph revealed, radiolucency in the coronal aspect involving pulp and periapical radiolucency involving the mesial root of 46 and furcal bone loss suggestive of dislodged restoration and secondary caries with periodontal involvement (Figure 1B). Thus the diagnosis was made as pulp necrosis with symptomatic apical periodontitis in relation to 46 [37] suggestive of primary endodontic lesion with secondary periodontal involvement [38].

Therapeutic intervention

Endodontic treatment was taken up first and then periodontal regenerative surgery was planned for treatment of the defect with alloplastic bone substitute and platelet rich fibrin (PRF). First visit: Patient was detailed about the treatment protocol, the number of visits, the merits and demerits of this procedure and alternate treatment options were explained in case the treatment failed. A written consent was taken from the patient before starting the procedure. No premedication was given. During the first visit, the patient was administered local anesthetic with vasoconstrictor (2% lidocaine with 1:100000 epinephrine). Rubber dam isolation was done and access cavity preparation done in 46 (Figure 1C). Working length determination was done using apex locator (J Morita) and confirmed radiographically(Figure 1D). Routine chemomechanical preparation was done in 46 using Protaper Gold Rotary files(Dentsply. Apical preparation was done upto F2 size for mesial canals and upto F3 for distal canal. 3% sodium hypochlorite, 17% EDTA and saline were used as irrigants and irrigant activation was performed using Sonic irrigant activation(Endoactivator), placing the tip, 2mm short of the working length. The canals were then dried using sterile paper points and calcium hydroxide(RC Cal, Prime dental products, India) was placed as intracanal medicament. Closed dressing was given using Intermediate restorative material and the patient was recalled after two weeks for obturation.

Second visit: During the second visit, the intracanal medicament was removed from the root canals and cleaning and shaping and irrigation protocol was repeated using 3% sodium hypochlorite and 17% EDTA final rinse for smear layer removal. The canals were then dried using sterile paper points and obturation was done using 6% gutta percha cones and AH plus sealer (Figure 1E,F). There was sealer extrusion seen in relation to mesial root of 46 (Figure 1F). The patient was administered pain analgesics (Zerodol P) twice a day for two days. Patient was recalled after 2 weeks for surgical management of furcal defect.

Third visit: When the patient reported after 2 weeks, the patient was completely asymptomatic but the probing depth was persistent (Figure 2A). The area selected for flap surgery was anesthetized using lignocaine with adrenaline 1: 1,50,000. A full thickness mucoperiosteal flap was elevated at the buccal aspect following intracrevicular incision in relation to 46 and the furcal defect was assessed (Figure 2B). The necrotic tissue was completely debrided using Gracey curettes #1-2 and 3-4, until the bleeding stopped. There were greenish calculus deposits found in the roots. Ultrasonic scaler tips(Satelac, Acteon) were used to remove the calculus and root planning was done. Meanwhile, 10ml of patient’s blood was collected and centrifuged for PRF [18, 39]. The PRF was made into a membrane. Bovine derived xenograft (Bio-Oss) was used [40]. The bone graft mixed with blood from PRF(Figure 2C) and was packed well into the furcal bony defect area and the PRF membrane was placed over it (Figure 2D,E). The flap was then approximated with non resorbable black silk (3-0) suture using interrupted suturing technique and periodontal dressing was placed (Figure 2F). The patient was advised antibiotics for 5 days and was recalled after a week for suture removal. Permanent full coverage restoration was planned after 3 to 6 months after the uneventful repair of the endo perio lesion (Figure 3A).

Follow up and outcome

The follow up schedule was given to the patient at 1,3,6 and 12 months according to Merin’s classification [41, 42]. The outcomes to be assessed include absence of mobility, reduction in probing depth, radiographic resolution of periapical and furcal radiolucency due to bone fill. Both clinical and radiological outcomes were successful at one year follow up. The probing depth was reduced to 2mm, there was good healing of the surgical site. Radiographically, substantial bone fill was seen in the periapical lesion of mesial root of 46 as well as the furcal defect (Figure 3B). The sealer extrusion in relation to mesial roots have also resolved [43].


Disscusion

The diagnosis of the key etiological factor is of prime importance in establishing the diagnosis of endo-perio lesions. The primary causative factor of the disease is microbial invasion and the rapidity of disease progression depends on the microbes present and its virulence.

The persistent nature of the endodontic pathogens is mainly due to biofilm formation which makes them firmly adherent to the root canal walls and this organised structure also makes them resistant to intracanal medicaments. Hence in our case, we have activated the irrigant sonically in order to facilitate biofilm removal as well as for the irrigant to reach all the inaccessible areas of the complex root canal system [44]. In many cases of endo perio cases with primary endodontic involvement, the periodontal regeneration occurs once the root canal treatment is performed. But in cases of furcation involvement, the rate of healing is hindered by the microbes still hiding in the inaccessible furcation areas [45]. In order to facilitate healing of the furcal bony defect, bone graft( xenograft) was placed which is osteoconductive in nature [46].

It serves as a matrix for bone growth. Platelet rich fibrin is an autologous platelet concentrate, which is rich in growth factors and highly biocompatible avoiding the possibility of immune rejection. PRF is a second generation platelet concentrate and is capable of progressive and sustained release of cytokines, TGF-ß, PDGF in high concentrations during remodeling of fibrin matrix. It may also be used as a membrane to stabilize the bone graft [39, 47]. Bone grafts may be autografts, allografts or xenografts that are osteoinductive or osteoconductive [20].

Thus the treatment of endo perio lesion requires both endodontic treatment as well as periodontal regenerative procedures to achieve long term good prognosis of the treated tooth. The treatment strategy primarily should focus on disinfection of the root canal system followed by an observational period. The goal of periodontal flap surgery is to debride all the necrotic tissues from the surgical site and facilitate the regeneration of hard and soft tissues along with the formation of new connective tissue apparatus [48].

Our institution is passionate about high quality evidence based research and has excelled in various fields [25, 49-58]. This has us to apply the concepts of autologous platelet concentrates in improving healing outcomes of endo perio lesions.



Figure 1. Endodontic intervention - (A) Preoperative clinical picture, (B) Preoperative IOPAR, (C) Access cavity picture, (D) Working length IOPAR, (E) Master cone IOPAR, (F) Obturation IOPAR.



Figure 2. Periodontal surgery as intervention- (A) Preoperative probing depths, (B) Flap elevation and curettage of the furcal defect, (C) Bone graft with PRF, (D) Bone graft placement at the site of defect, (E) Placement of membrane, (F) Suturing.



Figure 3. Follow up at 1 year (A) Clinical picture, (B) IOPAR.


Acknowledgement & Declaration

I would like to acknowledge my mentors and guide for helping me in case selection and treatment planning and the lab facilities for PRF preparation.


Conclusion

Multivisit endodontic therapy along with autologous platelet-rich derivatives and alloplastic bone substitute resulted in successful, clinical and radiological outcomes at one year follow up. There was gain in clinical attachment, reduction in probing depth, and radiographic bone fill and good healing of the surgical site.


References

  1. Kumar A, Tamanna S, Iftekhar H. Intracanal medicaments–Their use in modern endodontics: A narrative review. Journal of Oral Research and Review. 2019 Jul 1;11(2):94.
  2. Sundqvist G, Figdor D. Life as an endodontic pathogen: Ecological differences between the untreated and root-filled root canals. Endodontic Topics. 2003 Nov;6(1):3-28.
  3. Mohammadi Z, Palazzi F, Giardino L, Shalavi S. Microbial biofilms in endodontic infections: an update review. Biomed J. 2013 Mar-Apr;36(2):59-70. Pubmed PMID: 23644234.
  4. Siqueira JF, Rôças IN, Ricucci D. Biofilms in endodontic infection. Endodontic Topics. 2010 Mar;22(1):33-49.
  5. Russell CD, Schwarze J. The role of pro-resolution lipid mediators in infectious disease. Immunology. 2014 Feb;141(2):166-73. Pubmed PMID: 24400794.
  6. Siddiqui YD, Omori K, Ito T, Yamashiro K, Nakamura S, Okamoto K, et al. Resolvin D2 Induces Resolution of Periapical Inflammation and Promotes Healing of Periapical Lesions in Rat Periapical Periodontitis. Front Immunol. 2019 Feb 26;10:307. Pubmed PMID: 30863409.
  7. Govindaraju L, Gurunathan D. Effectiveness of Chewable Tooth Brush in Children-A Prospective Clinical Study. J Clin Diagn Res. 2017 Mar;11(3):ZC31-ZC34. Pubmed PMID: 28511505.
  8. Christabel A, Anantanarayanan P, Subash P, Soh CL, Ramanathan M, Muthusekhar MR, et al. Comparison of pterygomaxillary dysjunction with tuberosity separation in isolated Le Fort I osteotomies: a prospective, multi-centre, triple-blind, randomized controlled trial. Int J Oral Maxillofac Surg. 2016 Feb;45(2):180-5. Pubmed PMID: 26338075.
  9. Soh CL, Narayanan V. Quality of life assessment in patients with dentofacial deformity undergoing orthognathic surgery--a systematic review. Int J Oral Maxillofac Surg. 2013 Aug;42(8):974-80. Pubmed PMID: 23702370.
  10. Mehta M, Deeksha, Tewari D, Gupta G, Awasthi R, Singh H, et al. Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases. Chem Biol Interact. 2019 Aug 1;308:206- 215. Pubmed PMID: 31136735.
  11. Ezhilarasan D, Apoorva VS, Ashok Vardhan N. Syzygium cumini extract induced reactive oxygen species-mediated apoptosis in human oral squamous carcinoma cells. J Oral Pathol Med. 2019 Feb;48(2):115-121. Pubmed PMID: 30451321.
  12. Campeau PM, Kasperaviciute D, Lu JT, Burrage LC, Kim C, Hori M, et al. The genetic basis of DOORS syndrome: an exome-sequencing study. Lancet Neurol. 2014 Jan;13(1):44-58. Pubmed PMID: 24291220.
  13. Kumar S, Sneha S. Knowledge and awareness regarding antibiotic prophylaxis for infective endocarditis among undergraduate dental students. Asian Journal of Pharmaceutical and Clinical Research. 2016;154.
  14. Christabel SL, Gurunathan D. Prevalence of type of frenal attachment and morphology of frenum in children, Chennai, Tamil Nadu. World J Dent. 2015 Oct;6(4):203-7.
  15. Kumar S, Rahman RE. Knowledge, awareness, and practices regarding biomedical waste management among undergraduate dental students. Asian Journal of Pharmaceutical and Clinical Research. 2017;10(8):341.
  16. Sridharan G, Ramani P, Patankar S. Serum metabolomics in oral leukoplakia and oral squamous cell carcinoma. J Cancer Res Ther. 2017 Jul- Sep;13(3):556-561. Pubmed PMID: 28862226.
  17. Ramesh A, Varghese SS, Doraiswamy JN, Malaiappan S. Herbs as an antioxidant arsenal for periodontal diseases. J Intercult Ethnopharmacol. 2016 Jan 27;5(1):92-6. Pubmed PMID: 27069730.
  18. Thamaraiselvan M, Elavarasu S, Thangakumaran S, Gadagi JS, Arthie T. Comparative clinical evaluation of coronally advanced flap with or without platelet rich fibrin membrane in the treatment of isolated gingival recession. J Indian Soc Periodontol. 2015 Jan-Feb;19(1):66-71. Pubmed PMID: 25810596.
  19. Thangaraj SV, Shyamsundar V, Krishnamurthy A, Ramani P, Ganesan K, Muthuswami M, et al. Molecular Portrait of Oral Tongue Squamous Cell Carcinoma Shown by Integrative Meta-Analysis of Expression Profiles with Validations. PLoS One. 2016 Jun 9;11(6):e0156582. Pubmed PMID: 27280700.
  20. Ponnulakshmi R, Shyamaladevi B, Vijayalakshmi P, Selvaraj J. In silico and in vivo analysis to identify the antidiabetic activity of beta sitosterol in adipose tissue of high fat diet and sucrose induced type-2 diabetic experimental rats. Toxicol Mech Methods. 2019 May;29(4):276-290. Pubmed PMID: 30461321.
  21. Ramakrishnan M, Bhurki M. Fluoride, Fluoridated Toothpaste Efficacy And Its Safety In Children-Review. International Journal of Pharmaceutical Research. 2018 Oct 1;10(04):109-14.
  22. Vijayashree Priyadharsini J. In silico validation of the non-antibiotic drugs acetaminophen and ibuprofen as antibacterial agents against red complex pathogens. J Periodontol. 2019 Dec;90(12):1441-1448. Pubmed PMID: 31257588.
  23. J PC, Marimuthu T, C K, Devadoss P, Kumar SM. Prevalence and measurement of anterior loop of the mandibular canal using CBCT: A cross sectional study. Clin Implant Dent Relat Res. 2018 Aug;20(4):531-534. Pubmed PMID: 29624863.
  24. Ramesh A, Varghese S, Jayakumar ND, Malaiappan S. Comparative estimation of sulfiredoxin levels between chronic periodontitis and healthy patients - A case-control study. J Periodontol. 2018 Oct;89(10):1241-1248. Pubmed PMID: 30044495.
  25. Ramadurai N, Gurunathan D, Samuel AV, Subramanian E, Rodrigues SJL. Effectiveness of 2% Articaine as an anesthetic agent in children: randomized controlled trial. Clin Oral Investig. 2019 Sep;23(9):3543-3550. Pubmed PMID: 30552590.
  26. Sridharan G, Ramani P, Patankar S, Vijayaraghavan R. Evaluation of salivary metabolomics in oral leukoplakia and oral squamous cell carcinoma. J Oral Pathol Med. 2019 Apr;48(4):299-306. Pubmed PMID: 30714209.
  27. Ezhilarasan D, Apoorva VS, Ashok Vardhan N. Syzygium cumini extract induced reactive oxygen species-mediated apoptosis in human oral squamous carcinoma cells. J Oral Pathol Med. 2019 Feb;48(2):115-121. Pubmed PMID: 30451321.
  28. Mathew MG, Samuel SR, Soni AJ, Roopa KB. Evaluation of adhesion of Streptococcus mutans, plaque accumulation on zirconia and stainless steel crowns, and surrounding gingival inflammation in primary molars: randomized controlled trial. Clin Oral Investig. 2020 Sep;24(9):3275-3280. Pubmed PMID: 31955271.
  29. Samuel SR. Can 5-year-olds sensibly self-report the impact of developmental enamel defects on their quality of life? Int J Paediatr Dent. 2021 Mar;31(2):285-286. Pubmed PMID: 32416620.
  30. R H, Ramani P, Ramanathan A, R JM, S G, Ramasubramanian A, et al. CYP2 C9 polymorphism among patients with oral squamous cell carcinoma and its role in altering the metabolism of benzo[a]pyrene. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020 Sep;130(3):306-312. Pubmed PMID: 32773350.
  31. Chandrasekar R, Chandrasekhar S, Sundari KKS, Ravi P. Development and validation of a formula for objective assessment of cervical vertebral bone age. Prog Orthod. 2020 Oct 12;21(1):38. Pubmed PMID: 33043408.
  32. Vijayashree Priyadharsini J, Smiline Girija AS, Paramasivam A. In silico analysis of virulence genes in an emerging dental pathogen A. baumannii and related species. Arch Oral Biol. 2018 Oct;94:93-98. Pubmed PMID: 30015217.
  33. Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med. 2002 Oct 21;196(8):1025-37. Pubmed PMID: 12391014.
  34. Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014 Jun 5;510(7503):92-101. Pubmed PMID: 24899309.
  35. Colas RA, Shinohara M, Dalli J, Chiang N, Serhan CN. Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. Am J Physiol Cell Physiol. 2014 Jul 1;307(1):C39-54. Pubmed PMID: 24696140.
  36. Clària J, Dalli J, Yacoubian S, Gao F, Serhan CN. Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat. J Immunol. 2012 Sep 1;189(5):2597-605. Pubmed PMID: 22844113.
  37. Keelan JA, Mas E, D'Vaz N, Dunstan JA, Li S, Barden AE, et al. Effects of maternal n-3 fatty acid supplementation on placental cytokines, pro-resolving lipid mediators and their precursors. Reproduction. 2015 Feb;149(2):171-8. Pubmed PMID: 25504868.
  38. Arnardottir H, Orr SK, Dalli J, Serhan CN. Human milk proresolving mediators stimulate resolution of acute inflammation. Mucosal Immunol. 2016 May;9(3):757-766. Pubmed PMID: 26462421.
  39. Dalli J, Colas RA, Quintana C, Barragan-Bradford D, Hurwitz S, Levy BD, et al. Human Sepsis Eicosanoid and Proresolving Lipid Mediator Temporal Profiles: Correlations With Survival and Clinical Outcomes. Crit Care Med. 2017 Jan;45(1):58-68. Pubmed PMID: 27632672.
  40. Frediani JK, Jones DP, Tukvadze N, Uppal K, Sanikidze E, Kipiani M, et al. Plasma metabolomics in human pulmonary tuberculosis disease: a pilot study. PLoS One. 2014 Oct 15;9(10):e108854. Pubmed PMID: 25329995.
  41. Chiang N, de la Rosa X, Libreros S, Serhan CN. Novel Resolvin D2 Receptor Axis in Infectious Inflammation. J Immunol. 2017 Jan 15;198(2):842- 851. Pubmed PMID: 27994074.
  42. Mizraji G, Heyman O, Van Dyke TE, Wilensky A. Resolvin D2 Restrains Th1 Immunity and Prevents Alveolar Bone Loss in Murine Periodontitis. Front Immunol. 2018 Apr 25;9:785. Pubmed PMID: 29922275.
  43. Cotti E, Ideo F, Pedrazzini A, Bardini G, Musu D, Kantarci A. Proresolving Mediators in Endodontics: A Systematic Review. J Endod. 2021 May;47(5):711-720. Pubmed PMID: 33548330.
  44. Ali M, Yang F, Plachokova AS, Jansen JA, Walboomers XF. Application of specialized pro-resolving mediators in periodontitis and peri-implantitis: a review. Eur J Oral Sci. 2021 Feb;129(1):e12759. Pubmed PMID: 33565133.
  45. Spite M, Clària J, Serhan CN. Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases. Cell Metab. 2014 Jan 7;19(1):21-36. Pubmed PMID: 24239568.
  46. Spite M, Norling LV, Summers L, Yang R, Cooper D, Petasis NA, et al. Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature. 2009 Oct 29;461(7268):1287-91. Pubmed PMID: 19865173.
  47. Chiang N, Fredman G, Bäckhed F, Oh SF, Vickery T, Schmidt BA, et al. Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature. 2012 Apr 25;484(7395):524-8. Pubmed PMID: 22538616.
  48. Kurihara T, Jones CN, Yu YM, Fischman AJ, Watada S, Tompkins RG, et al. Resolvin D2 restores neutrophil directionality and improves survival after burns. FASEB J. 2013 Jun;27(6):2270-81. Pubmed PMID: 23430978.
  49. .
  50. Zhang MJ, Sansbury BE, Hellmann J, Baker JF, Guo L, Parmer CM, et al. Resolvin D2 Enhances Postischemic Revascularization While Resolving Inflammation. Circulation. 2016 Aug 30;134(9):666-680. Pubmed PMID: 27507404.
  51. Park CK, Xu ZZ, Liu T, Lü N, Serhan CN, Ji RR. Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1. J Neurosci. 2011 Dec 14;31(50):18433-8. Pubmed PMID: 22171045.
  52. Evans M, Davies JK, Sundqvist G, Figdor D. Mechanisms involved in the resistance of Enterococcus faecalis to calcium hydroxide. Int Endod J. 2002 Mar;35(3):221-8. Pubmed PMID: 11985673.
  53. Diogenes A, Henry MA, Teixeira FB, Hargreaves KM. An update on clinical regenerative endodontics. Endodontic Topics. 2013 Mar;28(1):2-3.

         Indexed in

pubhub  CGS  indexcoop  
j-gate  DOAJ  Google_Scholar_logo

       Total Visitors

SciDoc Counter

Get in Touch

SciDoc Publishers
16192 Coastal Highway
Lewes, Delaware 19958
Tel :+1-(302)-703-1005
Fax :+1-(302)-351-7355
Email: contact.scidoc@scidoc.org


porn